Cite
HARVARD Citation
Maurillo, L. et al. (n.d.). Minimal residual disease as biomarker for optimal biologic dosing of ARA‐C in patients with acute myeloid leukemia. American journal of hematology. 90 (2), pp. 125-131. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maurillo, L. et al. (n.d.). Minimal residual disease as biomarker for optimal biologic dosing of ARA‐C in patients with acute myeloid leukemia. American journal of hematology. 90 (2), pp. 125-131. [Online].